NNIT A/S: New Cloud Removes Barriers for Life Sciences

Udgivet den 01-02-2017  |  kl. 09:00  |  

Press release

New Cloud Removes Barriers for Life Sciences
New hybrid cloud solution helps life science companies implement their cloud strategies in compliance with latest regulatory requirements.

Copenhagen, February 1, 2017 - The new Enterprise Hybrid Cloud for life sciences is launched by NNIT, a leading provider of IT services and consultancy for the pharmaceutical industry. The enterprise hybrid cloud gives life science companies the opportunity to scale the use of the platform.

This service enables life science companies to comply with regulatory requirements when deploying workloads in Public Cloud (Based on Microsoft Azure) and Private Cloud (NNIT Datacenter) to be combined and connected in a Hybrid Cloud. The platform is qualified in compliance with regulatory requirements from European Medicines Agency and US Food and Drug Administration.

Success in a regulated industry requires the scalability and agile functionality delivered by the cloud. Executives tend to hold back from cloud migration, however, because of complex compliance requirements, e.g. to data integrity, data privacy and validation. The Enterprise Hybrid Cloud removes these barriers says Torben Thorhauge, Vice President of Infrastructure Outsourcing Life Sciences, NNIT.

The new solution ensures tight security and gives pharmaceutical companies full control of data. They also get global scalability, agile functionality and tailored service to help them keep costs in control while leveraging the benefits of the cloud.

The launch is part of NNIT's strategy to exploit its legacy and heritage from the pharmaceutical industry globally, explains Mette Steffensen, Senior Vice President, Life Sciences, NNIT:

The pharmaceutical industry applies very high standards for security, documentation and quality. This is part of our DNA, we have grown out of the life sciences industry so it's only natural that we develop a unique and competitive solution, which meets the companies' needs spot on, she says.

********
More information
Helga Heyn, NNIT Communications, +45 30 77 41 81, hhey@nnit.com

About NNIT Enterprise Hybrid Cloud Solution for Life Sciences
www.nnit.com/gxp-cloud

About NNIT
NNIT is an international consultancy in the development, implementation, validation and operation of IT for the life sciences industry. We create value for our clients by treating their IT as if it was our own, and of course, we meet the industry's strictest regulatory requirements. We apply the latest advances in technology to make our clients' software, business processes and communication more effective. NNIT A/S has more than 2,800 employees. For more information please visit www.nnit.com.

New Cloud Removes Barriers for Life Sciences


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NNIT A/S via Globenewswire

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

10:42 Meme-aktierne Gamestop og AMC ser ud til at fortsætte opturen
09:48 Svitzer får tirsdagens tredje købsanbefaling
09:18 Sydbank: Ser mulighed for lille positiv afsmitning til Vestas efter rivals meldinger
09:14 Aktier/åbning: Genmab og Ambu indtager C25-toppen før inflationstal
08:57 Obligationer/åbning: Flad start for renten før inflationstal og Powell-tale
08:55 Sydbank: Ser mulighed for lille positiv afsmitning til Vestas efter rivals meldinger
08:20 DFDS vil investere milliarder i batteridrevne skibe
08:18 Aktier/tendens: Novo og Genmab stjæler rampelyset forud for inflationstal
08:03 Sydbank: Fortsat forsigtighed i Ambus prognose - genopbygger stadig investortilliden
08:00 Fremgang i museumsbesøgene i 2023
08:00 Fortsat færre færgepassagerer end før COVID-19
07:59 Vestas-rival godt fra start i 2024 med indtjening noget over forventningerne
07:57 Sydbank: Fortsat forsigtighed i Ambus prognosen - genopbygger stadig investortilliden
07:33 GN og Demant-rival ser signifikante produktlanceringer accelerere væksten i 2024/25
07:31 Ambu leverer bredt funderet vækst og skærer endnu en luns af gælden
07:22 Råvarer: Oliepriserne stiger mens markedet venter inflationsindikatorer og Opec-rapport
07:20 Ambus overskud lander på linje med det ventede efter stærkt kvartal
07:15 Obligationer/tendens: Flad rentestart i sigte med fokus på inflation og Powell
06:45 Asien: Blandet stemning sætter gang i pendulsving
06:34 Rundspørge: Udsigt til to amerikanske rentesænkninger i år